Abstract
We write with great concern in response to the recent systematic review and meta-analysis of cognitive-behavioral therapy (CBT) in pediatric obsessive-compulsive disorder (OCD) by Uhre et al.1 Although the authors’ results consistently support the clinical efficacy of CBT for pediatric OCD, we expect that, much like ourselves, readers will be confused by the discordant and inappropriate conclusions that they put forward. These conclusions stem from the authors’ application and interpretation of their particular qualitative methods, which could lead important stakeholders (eg, parents, patients, clinicians, and payers) to wrongly discount clear evidence for what is known to be the best evidence-based therapy for pediatric OCD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 785-787 |
| Number of pages | 3 |
| Journal | Journal of the American Academy of Child and Adolescent Psychiatry |
| Volume | 59 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2020 |
Funding
Funding for this article was provided in part by a grant from the National Institute of Mental Health (NIMH) to Dr. Storch (1RF1MH121371). The views and opinions expressed in the present article represent those of the authors and do not necessarily reflect those of the National Institutes of Health (NIH) or the NIMH.Disclosure: Dr. Storch has received research funding from NIH, Texas Higher Education Coordinating Board, ReBuild Texas, Red Cross, Greater Houston Community Foundation, and McNair Foundation. He has been a paid consultant for Levo Therapeutics. He has received honoraria and travel support for lectures at academic institutions and from International OCD Foundation for behavior therapy trainings. He has received book royalties from Springer, Elsevier, Wiley, Oxford University Press, Guilford Press, American Psychological Association, and Jessica Kingsley. Dr. Peris has received research funding from NIMH and TLC Foundation for Body Focused Repetitive Behaviors (BFRBs). She has received consulting fees from Luminopia and royalties from Oxford University Press. Dr. Piacentini has received grant or research support from NIMH, TLC Foundation for BFRBs, and Pfizer Pharmaceuticals through the Duke University Clinical Research Institute Network. He is coauthor of Child OCD Impact Scale?Revised (COIS-R), Child Anxiety Impact Scale?Revised (CAIS-R), Parent Tic Questionnaire (PTQ), and Premonitory Urge for Tics Scale (PUTS) assessment tools, all of which are in the public domain and therefore no royalties are received. He has received honoraria and travel support for lectures at academic institutions and from TLC Foundation for BFRBs, Tourette Association of America, and International OCD Foundation for behavior therapy trainings. He has received publication royalties from Guilford Press and Oxford University Press. Dr. Bloch has received grant or research support from Therapix Biosciences, Neurocrine Biosciences, Janssen Pharmaceuticals, Biohaven Pharmaceuticals, NIH, National Alliance for Research on Schizophrenia and Depression (NARSAD), Lesbian Health Fund, Yale Foundation for Lesbian and Gay Studies (FLAGS), and Patterson Foundation. He has served on the advisory board/data monitoring and safety board of Therapix Biosciences. He has served as associate editor of Journal of Child Psychology and Psychiatry and on the editorial boards of Journal of Child and Adolescent Psychopharmacology and Depression and Anxiety. He has received royalties from Wolters Kluwer for Lewis's Child and Adolescent Psychiatry: A Comprehensive Textbook, Fifth Edition. He has received moonlighting pay from the Veteran's Administration. Dr. Cervin has received current funding from Bror Gadelius Foundation, Lions Research Foundation Sk?ne, Lindhaga Foundation, Sven Jerring Foundation, and Region Sk?ne. Dr. McGuire has received support from Tourette Association of America, American Academy of Neurology, Brain Research Foundation, American Psychological Foundation, and Hilda and Preston Davis Family Foundation. He has received royalties from Elsevier and has served as a consultant for Signant Health, Syneos Health, and Luminopia. Dr. McCracken has received consultant income from Roche, Octapharma, GW Biosciences, and Tris Pharmaceuticals, and he has received clinical trial research contracts from Roche. Dr. McKay has received royalties from Springer Publishing, Wiley, Elsevier, and Guilford Press. Dr. Franklin has received book royalties from Guildford Press. Dr. Walkup has received funding from Hartwell Foundation and Tourette Syndrome Association. He has served on the speakers? bureau for Tourette Syndrome Association. He has received book royalties from Guilford Press and Oxford University Press. Dr. Stewart has received grant or research support from American Academy of Child and Adolescent Psychiatry, Anxiety and Depression Association of America, International OCD Foundation, Canadian Institutes of Health Research, Michael Smith Foundation for Health Research, BC Children's Hospital Foundation, and Provincial Health Services Authority. She has served on the Scientific Clinical Advisory Board of International OCD Foundation and on the Scientific Advisory Board of Anxiety Canada. She is an author of the OCD Family Functioning (OFF) Scale. She has served on the editorial board of Journal of the Canadian Academy of Child and Adolescent Psychiatry. She has received honoraria from National Institute of Mental Health and Neuroscience, Yale Child Study Center, Aarhus University Hospital, International Anxiety Disorder Symposium, SickKids Hospital, Toronto, and Canadian Academy of Child and Adolescent Psychiatry. Dr. Goodman has received research funding from NIH, Biohaven Pharmaceuticals, and Mater Foundation. He has received honoraria from Biohaven Pharmaceuticals and Neurocrine. Drs. De Nadai, Farrell, Riemann, Wagner, Schneider, Williams, Abramowitz, and Fitzgerald have reported no biomedical financial interests or potential conflicts of interest. Funding acquisition: Storch. Funding for this article was provided in part by a grant from the National Institute of Mental Health (NIMH) to Dr. Storch (1RF1MH121371). The views and opinions expressed in the present article represent those of the authors and do not necessarily reflect those of the National Institutes of Health (NIH) or the NIMH.
ASJC Scopus subject areas
- Developmental and Educational Psychology
- Psychiatry and Mental health